Dr. Nathaniel Marc Schuster, MD

Dr. Schuster practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Schuster's NPI, 1861781205, was assigned on April 6, 2011. Dr. Schuster graduated from University Of Michigan Medical School in 2011. Dr. Schuster holds California license A125798.

Dr. Schuster's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Schuster's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Schuster is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schuster practices. Vendor and product names are available with a free account.

Pain medicine is Dr. Schuster's primary specialty in the NPI Registry, under taxonomy code 207LP2900X. Dr. Schuster is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Schuster's licenses on file in 3 states: California, Massachusetts and New York.

Dmand AI lists fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain, migraine and chronic headache, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, nerve damage and neuropathy among the conditions Dr. Schuster treats.

CMS data shows 914 Medicare services from Dr. Schuster across 21 procedure codes in 2024, for 266 Medicare patients. Medicare paid $60,895 for them.

CMS counts 266 Medicare patients who saw Dr. Schuster in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have arthritis, and 74% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schuster's median patient age at 61, with 66% women.

In 2024, Dr. Schuster wrote 145 Medicare Part D claims for 34 patients. 68% of them were for generic drugs. CMS names the drug for 51 of them, across 3 drugs with 11 or more claims each, at $37,151 in total drug cost. In 2023, CMS named 49 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Schuster for performance year 2024, reported as part of a group. Dr. Schuster accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schuster as offering telehealth.

Dmand AI links 50 papers to Dr. Schuster, published from 2015 to 2025. 2024 was the busiest year, with 4. The most frequent topics are Migraine Disorders, Chronic Pain and Headache. Dr. Schuster has published most often in Pain Med. Dr. Schuster's most frequent co-authors are Joel P. Castellanos, MD, Ameet S. Nagpal, MD, MS and Jessica Oswald, MD.

Dmand AI links Dr. Schuster to 2 clinical trials, 2 of them phase 2 studies. Conditions studied include Marijuana Abuse, Sleep Initiation and Maintenance Disorders and Chronic Pain. University of California, San Diego sponsors the most, 2.

CMS Open Payments shows 550 general payments to Dr. Schuster from 30 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 34% of the total. Eli Lilly and Company paid the most, $128,050.

Dmand AI lists 5 awards for Dr. Schuster, most recently Impact Award in 2018. Dr. Schuster serves on American Academy of Neurology/American Headache Society, American Academy of Pain Medicine and North American Neuromodulation Society.

Dr. Schuster graduated from University Of Michigan Medical School in 2011. Dr. Schuster is a member of AAN, American Academy of Pain Medicine, American Headache Society and Spine Intervention Society.

Dr. Schuster is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.